These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6872170

  • 21. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F, Bracchetti D, Palmieri M, Marchesini B, Ambrosioni E.
    Am J Cardiol; 1984 Nov 01; 54(8):1008-14. PubMed ID: 6496321
    [Abstract] [Full Text] [Related]

  • 22. [Long-term treatment with the new antiarrhythmic drug propafenone in correlation to plasma levels (author's transl)].
    Wiebringhaus E, Seipel L, Breithardt G, Loogen F.
    Z Kardiol; 1977 Nov 01; 66(11):625-32. PubMed ID: 22958
    [Abstract] [Full Text] [Related]

  • 23. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 01; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 24. [Clinical pharmacology of propafenone].
    Ambrosioni E, Marchesini B.
    G Ital Cardiol; 1984 Apr 01; 14(4):285-92. PubMed ID: 6735021
    [Abstract] [Full Text] [Related]

  • 25. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 01; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 26. [Antiarrhythmic effect of propafenone in relation to serum concentration and conduction time (author's transl)].
    Meyer-Estorf G, Keller K, Beck OA, Hochrein H.
    Z Kardiol; 1978 May 01; 67(5):353-6. PubMed ID: 654420
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG, Kirsten EB, Brewington J.
    Clin Pharmacol Ther; 1989 May 01; 45(5):535-41. PubMed ID: 2721109
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration.
    Giani P, Landolina M, Giudici V, Bianchini C, Ferrario G, Marchi S, Riva E, Latini R.
    Eur J Clin Pharmacol; 1988 May 01; 34(2):187-94. PubMed ID: 3383990
    [Abstract] [Full Text] [Related]

  • 29. [Therapy of ventricular arrhythmias with propafenone].
    Petri H, Kafka W, Rudolph W.
    Herz; 1985 Feb 01; 10(1):44-52. PubMed ID: 2579879
    [Abstract] [Full Text] [Related]

  • 30. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW, Nayebagha A, Fabry E.
    Z Kardiol; 1982 May 01; 71(5):340-9. PubMed ID: 6180562
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA, Murphy ML, Baker BJ, deSoyza N, Franciosa JA.
    Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [Abstract] [Full Text] [Related]

  • 32. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
    Sanna G, Meoli P, Bianchini C, Rovelli F.
    G Ital Cardiol; 1983 Jun 01; 13(3):145-51. PubMed ID: 6350090
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo].
    Purcaro A, Amici R, Ciampani N, Costantini C, Mocchegiani R, Pigini G.
    G Ital Cardiol; 1983 Jun 01; 13(6):444-50. PubMed ID: 6357929
    [Abstract] [Full Text] [Related]

  • 34. Metabolite cumulation during chronic propafenone dosing in arrhythmia.
    Kates RE, Yee YG, Winkle RA.
    Clin Pharmacol Ther; 1985 Jun 01; 37(6):610-4. PubMed ID: 4006362
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F, Palmieri M, del Corso P, Lombardi G, Bracchetti D.
    Arzneimittelforschung; 1982 Jun 01; 32(5):547-50. PubMed ID: 7201833
    [Abstract] [Full Text] [Related]

  • 36. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P, De Toma L, Mangini SG, Scrutinio D, Lagioia R, De Nicolò M.
    Cardiologia; 1983 Sep 01; 28(9):791-801. PubMed ID: 6398703
    [No Abstract] [Full Text] [Related]

  • 37. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F, Disertori M, Vergara G, Guarnerio M, Dal Forno P, Padrini R, Gobbato S, Ferrari M.
    Int J Clin Pharmacol Res; 1983 Sep 01; 3(2):101-5. PubMed ID: 6679511
    [Abstract] [Full Text] [Related]

  • 38. Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.
    Keller K, Meyer-Estorf G, Beck OA, Hochrein H.
    Eur J Clin Pharmacol; 1978 Mar 17; 13(1):17-20. PubMed ID: 639829
    [Abstract] [Full Text] [Related]

  • 39. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
    Winkle RA, Keefe DL, Rodriguez I, Kates RE.
    Am J Cardiol; 1984 Feb 01; 53(4):544-51. PubMed ID: 6198895
    [Abstract] [Full Text] [Related]

  • 40. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ, Kates RE, Lebsack CS, Echt DS, Mason JW, Winkle RA.
    Am J Cardiol; 1983 Dec 01; 52(10):1208-13. PubMed ID: 6359849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.